Table 2.
The final prognostic risk score model for GBM patients.
| EMT-related lncRNA | HR | 95% lower HR | 95% higher HR | P value | Coefficient |
|---|---|---|---|---|---|
| AC012615.1 | 0.63516 | 0.471687 | 0.855288 | 0.002794 | − 0.45388 |
| H19 | 1.086364 | 0.986396 | 1.196463 | 0.092597 | 0.082836 |
| LINC00609 | 1.426481 | 0.921887 | 2.207265 | 0.110757 | 0.355211 |
| LINC00634 | 0.802278 | 0.61518 | 1.046278 | 0.103939 | − 0.2203 |
| POM121L9P | 1.457718 | 1.012034 | 2.099673 | 0.042948 | 0.376872 |
| SNHG11 | 1.81924 | 1.229622 | 2.691585 | 0.002751 | 0.598419 |
| USP32P3 | 0.752526 | 0.555687 | 1.01909 | 0.066101 | − 0.28432 |
EMT epithelial-mesenchymal transition, GBM Glioblastoma, HR hazard ratio.